Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- None.
- None.
The presentation will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at https://investors.dynavax.com/events-presentations.
About Dynavax
Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the
For Investors/Media:
Paul Cox
pcox@dynavax.com
510-665-0499
Nicole Arndt
narndt@dynavax.com
510-665-7264
View original content to download multimedia:https://www.prnewswire.com/news-releases/dynavax-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302025790.html
SOURCE Dynavax Technologies
FAQ
When will Dynavax Technologies Corporation present at the 42nd Annual J.P. Morgan Healthcare Conference?
Where can I access the webcast of Dynavax Technologies Corporation's presentation at the 42nd Annual J.P. Morgan Healthcare Conference?